RON Receptor-Targeted Antibody-Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Long-term Tumor Regressions in Preclinical Models of Triple-Negative Breast Cancer (TNBC)

被引：0
|
作者：
Suthe, Sreedhar Reddy
Yao, Hang-Ping
Wang, Ming-Hai
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
510.3
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Antitumor effect of a novel humanized MUC1 antibody-drug conjugate on triple-negative breast cancer
    Li, Lan
    Cao, Jiawei
    Chen, Chunyan
    Qin, Yaqian
    He, Licai
    Gu, Haihua
    Wu, Guang
    HELIYON, 2023, 9 (04)
  • [22] Anti-uPAR antibody drug conjugates for targeted therapy of triple-negative breast cancer
    Harel, Efrat
    McFarland, Jesse
    Bleck, Gregory
    Brain, Susie
    Drake, Penelope
    Rabuka, David
    Vantveer, Laura
    Craik, Charles
    CANCER RESEARCH, 2018, 78 (04)
  • [23] Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer (TNBC) in a Peruvian institute.
    Ingrid Rojas, Katerin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer
    Huang, Wenpeng
    Li, Liming
    Zhou, Yuhan
    Yang, Qi
    Mixdorf, Jason C.
    Barnhart, Todd E.
    Hsu, Jessica C.
    Saladin, Rachel J.
    Liu, Chihao
    Rosenkrans, Zachary T.
    Engle, Jonathan W.
    Gao, Jianbo
    Kang, Lei
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [25] Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
    Cordani, Nicoletta
    Lisini, Daniela
    Cocce, Valentina
    Paglia, Giuseppe
    Meanti, Ramona
    Cerrito, Maria Grazia
    Tettamanti, Pietro
    Bonaffini, Luca
    Paino, Francesca
    Alessandri, Giulio
    Marcianti, Angela
    Gianni, Aldo
    Villa, Chiara
    Mauri, Mario
    Mologni, Luca
    Torsello, Antonio
    Pessina, Augusto
    Cazzaniga, Marina Elena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [26] HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells
    Xia, Leiming
    Wen, Lu
    Qin, You
    Dobson, Hannah E.
    Zhang, Tao
    Comer, Frank, I
    Hinrichs, Mary Jane
    Oberst, Michael D.
    Coats, Steven R.
    Chang, Alfred E.
    Liu, Yuanyuan
    Bao, Yangyi
    Dai, Fu
    Wicha, Max S.
    Li, Qiao
    CELL CHEMICAL BIOLOGY, 2021, 28 (05): : 610 - +
  • [27] In vitro anti-cancer effects of gefitinib via EGF receptor-targeted delivery on triple-negative breast cancer cells
    Ahn, Jae Won
    Song, Yeong Jun
    Park, Kyeongsoon
    MACROMOLECULAR RESEARCH, 2023, 31 (09) : 837 - 842
  • [28] In vitro anti-cancer effects of gefitinib via EGF receptor-targeted delivery on triple-negative breast cancer cells
    Jae Won Ahn
    Yeong Jun Song
    Kyeongsoon Park
    Macromolecular Research, 2023, 31 : 837 - 842
  • [29] Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
    Liedtke, Cornelia
    Mazouni, Chafika
    Hess, Kenneth R.
    Andre, Fabrice
    Tordai, Attila
    Mejia, Jaime A.
    Symmans, W. Fraser
    Gonzalez-Angulo, Ana M.
    Hennessy, Bryan
    Green, Marjorie
    Cristofanilli, Massimo
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1275 - 1281
  • [30] Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
    Paulmurugan, Ramasamy
    Bhethanabotla, Rohith
    Mishra, Kaushik
    Devulapally, Rammohan
    Foygel, Kira
    Sekar, Thillai V.
    Ananta, Jeyarama S.
    Massoud, Tarik F.
    Joy, Abraham
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (02) : 221 - 231
12345